Induction of broadly cross-reactive neutralizing antibodies is a excessive precedence for AIDS vaccine growth however one which has confirmed troublesome to be achieved. While most immunogens generate antibodies that neutralize a subset of T-cell-line-adapted strains of human immunodeficiency virus type 1 (HIV-1), none to this point have generated a potent, broadly cross-reactive response in opposition to major isolates of the virus.
Even small increments in immunogen enchancment resulting in will increase in neutralizing antibody titers and cross-neutralizing exercise would speed up vaccine growth; nonetheless, a scarcity of uniformity in goal strains utilized by totally different investigators to evaluate cross-neutralization has made the comparability of vaccine-induced antibody responses troublesome. Thus, there’s an pressing want to determine commonplace panels of HIV-1 reference strains for broad distribution.
To facilitate this, full-length gp160 genes have been cloned from acute and early subtype B infections and characterised for use as reference reagents to evaluate neutralizing antibodies in opposition to clade B HIV-1. Individual gp160 clones have been screened for infectivity as Env-pseudotyped viruses in a luciferase reporter gene assay in JC53-BL (TZM-bl) cells. Functional env clones have been sequenced and their neutralization phenotypes characterised through the use of soluble CD4, monoclonal antibodies, and serum samples from contaminated people and noninfected recipients of a recombinant gp120 vaccine.
Env clones from 12 R5 major HIV-1 isolates have been chosen that weren’t unusually delicate or immune to neutralization and comprised a large spectrum of genetic, antigenic, and geographic range. These reference reagents will facilitate proficiency testing and different validation efforts aimed toward bettering assay efficiency throughout laboratories and can be utilized for standardized assessments of vaccine-elicited neutralizing antibodies.
Wnt proteins are lipid-modified and can act as stem cell progress components.
Wnt signalling is concerned in quite a few occasions in animal growth, together with the proliferation of stem cells and the specification of the neural crest. Wnt proteins are probably essential reagents in increasing particular cell varieties, however in distinction to different developmental signalling molecules equivalent to hedgehog proteins and the bone morphogenetic proteins, Wnt proteins have by no means been remoted in an energetic type.
Although Wnt proteins are secreted from cells, secretion is often inefficient and earlier makes an attempt to characterize Wnt proteins have been hampered by their excessive diploma of insolubility. Here we have now remoted energetic Wnt molecules, together with the product of the mouse Wnt3a gene. By mass spectrometry, we discovered the proteins to be palmitoylated on a conserved cysteine.
Enzymatic elimination of the palmitate or site-directed and pure mutations of the modified cysteine end in loss of exercise, and point out that the lipid is essential for signalling. The purified Wnt3a protein induces self-renewal of haematopoietic stem cells, signifying its potential use in tissue engineering.
RGD and different recognition sequences for integrins.
Proteins that include the Arg-Gly-Asp (RGD) attachment web site, along with the integrins that function receptors for them, represent a serious recognition system for cell adhesion. The RGD sequence is the cell attachment web site of a big quantity of adhesive extracellular matrix, blood, and cell floor proteins, and almost half of the over 20 recognized integrins acknowledge this sequence of their adhesion protein ligands.
Some different integrins bind to associated sequences of their ligands. The integrin-binding exercise of adhesion proteins will be reproduced by quick artificial peptides containing the RGD sequence. Such peptides promote cell adhesion when insolubilized onto a floor, and inhibit it when offered to cells in answer. Reagents that bind selectively to just one or just a few of the RGD-directed integrins will be designed by cyclizing peptides with chosen sequences across the RGD and by synthesizing RGD mimics.
As the integrin-mediated cell attachment influences and regulates cell migration, progress, differentiation, and apoptosis, the RGD peptides and mimics can be utilized to probe integrin capabilities in numerous organic programs. Drug design primarily based on the RGD construction could present new therapies for ailments equivalent to thrombosis, osteoporosis, and most cancers.
Quantification of mRNA utilizing real-time reverse transcription PCR (RT-PCR): traits and issues.
The fluorescence-based real-time reverse transcription PCR (RT-PCR) is extensively used for the quantification of steady-state mRNA ranges and is a crucial device for fundamental analysis, molecular medication and biotechnology. Assays are straightforward to carry out, succesful of excessive throughput, and can mix excessive sensitivity with dependable specificity. The know-how is evolving quickly with the introduction of new enzymes, chemistries and instrumentation.
However, whereas real-time RT-PCR addresses many of the difficulties inherent in standard RT-PCR, it has turn out to be more and more clear that it engenders new issues that require pressing consideration. Therefore, along with offering a snapshot of the state-of-the-art in real-time RT-PCR, this overview has a further goal: it’ll describe and talk about critically some of the issues related to deciphering outcomes which can be numerical and lend themselves to statistical evaluation, but whose accuracy is considerably affected by reagent and operator variability.
Reagents that inhibit the ubiquitin-proteasome proteolytic pathway in cells haven’t been out there. Peptide aldehydes that inhibit main peptidase actions of the 20S and 26S proteasomes are proven to cut back the degradation of protein and ubiquitinated protein substrates by 26S particles.
Unlike inhibitors of lysosomal proteolysis, these compounds inhibit the degradation of not solely irregular and short-lived polypeptides but in addition long-lived proteins in intact cells. We used these brokers to check the significance of the proteasome in antigen presentation. When ovalbumin is launched into the cytosol of lymphoblasts, these inhibitors block the presentation on MHC class I molecules of an ovalbumin-derived peptide by stopping its proteolytic technology.
SRPX (NM_001170752) Human Over-expression Lysate |
|||
| E45H00489-2 | EnoGene | each | 395 EUR |
SRPX (NM_006307) Human Over-expression Lysate |
|||
| E45H18537-2 | EnoGene | 20 ug | 395 EUR |
SRPX (NM_006307) Human Over-expression Lysate |
|||
| LS008406 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of sushi-repeat-containing protein, X-linked (SRPX), transcript variant 1 |
|||
SRPX Over-expression Lysate Product |
|||
| GWB-44B096 | GenWay Biotech | 0.1 mg | Ask for price |
Human SRPX2 Protein Lysate |
|||
| MBS8427852-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Human SRPX2 Protein Lysate 20ug |
|||
| IHUSRPX2PLLY20UG | Innovative research | each | 211 EUR |
|
Description: Human SRPX2 Protein Lysate 20ug |
|||
OCOA02119-20UG - SRPX2 Protein Lysate |
|||
| OCOA02119-20UG | Aviva Systems Biology | 20ug | 169 EUR |
EP Reagent Biuret Reagent - 100ML |
|||
| 1011601 | Scientific Laboratory Supplies | 1L | 59.4 EUR |
PEROXIDE BLOCKING REAGENT Reagent |
|||
| GWB-Q00308 | GenWay Biotech | 50 ml | Ask for price |
SRP72 Over-expression Lysate Product |
|||
| GWB-E4350D | GenWay Biotech | 0.1 mg | Ask for price |
SRP19 Over-expression Lysate Product |
|||
| GWB-EAEAE1 | GenWay Biotech | 0.1 mg | Ask for price |
EP Reagent Iodoplatinate Reagent - 200ML |
|||
| 1046300 | Scientific Laboratory Supplies | 200ML | 502.2 EUR |
EP Reagent Molybdovanadic Reagent - 100ML |
|||
| 1056700 | Scientific Laboratory Supplies | 100ML | 59.4 EUR |
SRP9 Over-expression Lysate Product |
|||
| GWB-88F1AF | GenWay Biotech | 0.1 mg | Ask for price |
EP Reagent Methoxyphenylacetic Reagent - 100ML |
|||
| 1053601 | Scientific Laboratory Supplies | 100ML | 490.05 EUR |
Protein expression |
|||
| CRO-4-Ind | Jotbody | each | Ask for price |
EP Reagent Phosphomolybdotungstic Reagent - 100ML |
|||
| 1065000 | Scientific Laboratory Supplies | 100ML | 226.8 EUR |
RFP expression Adenovirus, in vivo ready |
|||
| AVP001-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made RFP expression adenovirus, provided in PBS solution. |
|||
CFP expression Adenovirus, in vivo ready |
|||
| AVP002-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made CFP expression adenovirus, provided in PBS solution. |
|||
GFP expression Adenovirus, in vivo ready |
|||
| AVP011-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made GFP expression adenovirus, provided in PBS solution. |
|||
YFP expression Adenovirus, in vivo ready |
|||
| AVP012-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made YFP expression adenovirus, provided in PBS solution. |
|||
BFP expression Adenovirus, in vivo ready |
|||
| AVP017-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made BFP expression adenovirus, provided in PBS solution. |
|||
SRP54 (NM_003136) Human Over-expression Lysate |
|||
| E45H06528-2 | EnoGene | each | 395 EUR |
SRP19 (NM_003135) Human Over-expression Lysate |
|||
| E45H06529-2 | EnoGene | each | 395 EUR |
SRP14 (NM_003134) Human Over-expression Lysate |
|||
| E45H06530-2 | EnoGene | each | 395 EUR |
SRP72 (NM_006947) Human Over-expression Lysate |
|||
| E45H08437-2 | EnoGene | each | 395 EUR |
SRP68 (NM_014230) Human Over-expression Lysate |
|||
| E45H09072-2 | EnoGene | each | 395 EUR |
SRP54 (NM_001146282) Human Over-expression Lysate |
|||
| E45H01023-2 | EnoGene | each | 395 EUR |
SRP14 (NM_003134) Human Over-expression Lysate |
|||
| LS006727 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of signal recognition particle 14kDa (homologous Alu RNA binding protein) (SRP14) |
|||
SRP19 (NM_003135) Human Over-expression Lysate |
|||
| LS006728 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of signal recognition particle 19kDa (SRP19) |
|||
SRP54 (NM_003136) Human Over-expression Lysate |
|||
| LS006729 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of signal recognition particle 54kDa (SRP54), transcript variant 1 |
|||
SRP68 (NM_014230) Human Over-expression Lysate |
|||
| LS006730 | BosterBio | 100ug | 960 EUR |
|
Description: Transient overexpression lysate of signal recognition particle 68kDa (SRP68) |
|||
SRP72 (NM_006947) Human Over-expression Lysate |
|||
| LS006731 | BosterBio | 100ug | 960 EUR |
|
Description: Transient overexpression lysate of signal recognition particle 72kDa (SRP72) |
|||
SRP9 (NM_003133) Human Over-expression Lysate |
|||
| E45H06531-2 | EnoGene | each | 395 EUR |
SRP9 (NM_003133) Human Over-expression Lysate |
|||
| LS006726 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of signal recognition particle 9kDa (SRP9), transcript variant 2 |
|||
AVIDIN/BIOTIN BLOCKING REAGENT Reagent |
|||
| GWB-Q00289 | GenWay Biotech | 30 ml | Ask for price |
Gordon-McLeod Reagent (Oxidase reagent) |
|||
| R026-100ML | EWC Diagnostics | 1 unit | 7.76 EUR |
|
Description: Gordon-McLeod Reagent (Oxidase reagent) |
|||
Oxidase Reagent (Gordon-Macleod Reagent) |
|||
| 76207 | Sisco Laboratories | 100 ml | 3.38 EUR |
|
Description: Part B |
|||
YLEX Expression Kit |
|||
| FYY201-1KT | Yeastern Biotech | 1 kit | Ask for price |
EP Reagent Sulfomolybdic Reagent R3 - 1L |
|||
| 1086500 | Scientific Laboratory Supplies | 1L | 398.25 EUR |
TRIpure Reagent (same as Trizol Reagent) |
|||
| MBS356001-INQUIRE | MyBiosource | INQUIRE | Ask for price |
h OCT4 expression Adenovirus, in vivo ready |
|||
| AVP013-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in PBS solution for in vivo application. |
|||
h SOX2 expression Adenovirus, in vivo ready |
|||
| AVP014-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in PBS solution for in vivo application. |
|||
SRPK1 Over-expression Lysate Product |
|||
| GWB-40D9D6 | GenWay Biotech | 0.1 mg | Ask for price |
SRPK2 Over-expression Lysate Product |
|||
| GWB-D801BD | GenWay Biotech | 0.1 mg | Ask for price |
SRPRB Over-expression Lysate Product |
|||
| GWB-C2D4F4 | GenWay Biotech | 0.1 mg | Ask for price |
SRPK3 Over-expression Lysate Product |
|||
| GWB-CB541C | GenWay Biotech | 0.1 mg | Ask for price |
293 Expression MAX-1 |
|||
| EXP-711-11 | ACROBIOSYSTEMS | 1ml | 218 EUR |
|
Description: 293 Expression MAX-1 is expressed from - -. |
|||
h LIN28 expression Adenovirus, in vivo ready |
|||
| AVP015-PBS | GenTarget | 1x1011 IFU/ml x 50ul | 455 EUR |
|
Description: pre-made adenovirus express human stem cell factor, LIN28, provided in PBS solution for in vivo application. |
|||
Total RNA Isolation Reagent (Reagent Based) |
|||
| MBS402052-100mL | MyBiosource | 100mL | 235 EUR |
Total RNA Isolation Reagent (Reagent Based) |
|||
| MBS402052-4Reactions | MyBiosource | 4Reactions | 165 EUR |
Genomic DNA Isolation Reagent (Reagent Based) |
|||
| MBS402050-100mL | MyBiosource | 100mL | 255 EUR |
Genomic DNA Isolation Reagent (Reagent Based) |
|||
| MBS402050-4Reactions | MyBiosource | 4Reactions | 185 EUR |
CNGA2 Expression vector |
|||
| 60642 | BPS Bioscience | 20 µg | 900 EUR |
|
Description: The CNGA2 expression vector is designed to express human cyclic nucleotide-gated cation channel 2 (CNGA2) in mammalian cells. |
|||
CNGA2 Expression vector |
|||
| GWB-PSFA61 | GenWay Biotech | 20ug | Ask for price |
pYLEX1 - Expression Vector |
|||
| FYY203-5MG | Yeastern Biotech | 5mg | Ask for price |
LEXSYcon2.1 Expression Kit |
|||
| EGE-1310ble | Jena Bioscience GmbH | 1Kit | 979.85 EUR |
|
Description: for constitutive cytosolic or secretory protein expression |
|||
LEXSYcon2.1 Expression Kit |
|||
| EGE-1310bsd | Jena Bioscience GmbH | 1Kit | 979.85 EUR |
|
Description: for constitutive cytosolic or secretory protein expression |
|||
LEXSYcon2.1 Expression Kit |
|||
| EGE-1310hyg | Jena Bioscience GmbH | 1Kit | 979.85 EUR |
|
Description: for constitutive cytosolic or secretory protein expression |
|||
LEXSYcon2.1 Expression Kit |
|||
| EGE-1310neo | Jena Bioscience GmbH | 1Kit | 979.85 EUR |
|
Description: for constitutive cytosolic or secretory protein expression |
|||
LEXSYcon2.1 Expression Kit |
|||
| EGE-1310pac | Jena Bioscience GmbH | 1Kit | 979.85 EUR |
|
Description: for constitutive cytosolic or secretory protein expression |
|||
LEXSYcon2.1 Expression Kit |
|||
| EGE-1310sat | Jena Bioscience GmbH | 1Kit | 979.85 EUR |
|
Description: for constitutive cytosolic or secretory protein expression |
|||
Blunt E1 Expression Kit |
|||
| abx098098-100l | Abbexa | 100 µl | 712.5 EUR |
Blunt E1 Expression Kit |
|||
| abx098098-10rxns | Abbexa | 10 rxns | 560.4 EUR |
Blunt E1 Expression Kit |
|||
| abx098098-1ml | Abbexa | 1 ml | Ask for price |
Blunt E1 Expression Kit |
|||
| abx098098-200l | Abbexa | 200 µl | Ask for price |
Blunt E2 Expression Kit |
|||
| abx098873-100l | Abbexa | 100 µl | 712.5 EUR |
Blunt E2 Expression Kit |
|||
| abx098873-10rxns | Abbexa | 10 rxns | 560.4 EUR |
Blunt E2 Expression Kit |
|||
| abx098873-1ml | Abbexa | 1 ml | Ask for price |
Blunt E2 Expression Kit |
|||
| abx098873-200l | Abbexa | 200 µl | Ask for price |
RFP expression Adenovirus |
|||
| AVP001 | GenTarget | 1x109 IFU/ml x 200ul | 206.5 EUR |
|
Description: pre-made RFP expression adenovirus, provided in DMEM medium. |
|||
CFP expression Adenovirus |
|||
| AVP002 | GenTarget | 1x109 IFU/ml x 200ul | 206.5 EUR |
|
Description: pre-made CFP expression adenovirus, provided in DMEM medium. |
|||
GFP expression Adenovirus |
|||
| AVP011 | GenTarget | 1x109 IFU/ml x 200ul | 206.5 EUR |
|
Description: pre-made GFP expression adenovirus, provided in DMEM medium. |
|||
YFP expression Adenovirus |
|||
| AVP012 | GenTarget | 1x109 IFU/ml x 200ul | 206.5 EUR |
|
Description: pre-made YFP expression adenovirus, provided in DMEM medium. |
|||
BFP expression Adenovirus |
|||
| AVP017 | GenTarget | 1x109 IFU/ml x 200ul | 206.5 EUR |
|
Description: pre-made BFP expression adenovirus, provided in DMEM medium. |
|||
LEXSinduce3 Expression Kit |
|||
| EGE-1410ble | Jena Bioscience GmbH | 1Kit | 2296.43 EUR |
|
Description: for inducible cytosolic or secretory protein expression |
|||
LEXSinduce3 Expression Kit |
|||
| EGE-1410blecherry | Jena Bioscience GmbH | 1Kit | 2296.43 EUR |
|
Description: for inducible cytosolic or secretory protein expression |
|||
LEXSinduce3 Expression Kit |
|||
| EGE-1410neo | Jena Bioscience GmbH | 1Kit | 2296.43 EUR |
|
Description: for inducible cytosolic or secretory protein expression |
|||
LEXSinduce4 Expression Kit |
|||
| EGE-1420blecherry | Jena Bioscience GmbH | 1Kit | 2296.43 EUR |
|
Description: for inducible cytosolic or secretory protein expression |
|||
Rac1 Expression Vector Set |
|||
| STA-454 | Cell Biolabs | 1 kit | 1765.2 EUR |
|
Description: Rac1 Expression Vector Set contains 3 vectors: Rac wild type, T17N dominant negative mutant, and G12V constitutively active mutant. |
|||
RhoA Expression Vector Set |
|||
| STA-456 | Cell Biolabs | 1 kit | 1765.2 EUR |
|
Description: RhoA Expression Vector Set contains 3 vectors: RhoA wild type, T19N dominant negative mutant, and G14V constitutively active mutant. |
|||
Plant Total RNA Isolation Reagent (Reagent Based) |
|||
| MBS402053-100mL | MyBiosource | 100mL | 245 EUR |
Plant Total RNA Isolation Reagent (Reagent Based) |
|||
| MBS402053-4Reactions | MyBiosource | 4Reactions | 165 EUR |
OPN expression inhibitor 1 |
|||
| HY-146064 | MedChemExpress | 10 mg | 2272.76 EUR |
|
Description: OPN expression inhibitor 1 (Compound 11) is an osteopontin (OPN) expression inhibitor. OPN expression inhibitor 1 can be used for breast cancer research[1]. |
|||
Cdc42 Expression Vector Set |
|||
| STA-455 | Cell Biolabs | 1 kit | 1765.2 EUR |
|
Description: Cdc42 Expression Vector Set contains 3 vectors: Cdc42 wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. |
|||
OPN expression inhibitor 1 |
|||
| T62820-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: OPN expression inhibitor 1 |
|||
OPN expression inhibitor 1 |
|||
| T62820-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: OPN expression inhibitor 1 |
|||
OPN expression inhibitor 1 |
|||
| T62820-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: OPN expression inhibitor 1 |
|||
OPN expression inhibitor 1 |
|||
| T62820-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: OPN expression inhibitor 1 |
|||
OPN expression inhibitor 1 |
|||
| T62820-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: OPN expression inhibitor 1 |
|||
Plant Genomic DNA Isolation Reagent (Reagent Based) |
|||
| MBS402051-100mL | MyBiosource | 100mL | 245 EUR |
Plant Genomic DNA Isolation Reagent (Reagent Based) |
|||
| MBS402051-4Reactions | MyBiosource | 4Reactions | 165 EUR |
SRPK1 (NM_003137) Human Over-expression Lysate |
|||
| E45H19280-2 | EnoGene | 20 ug | 395 EUR |
SRPK2 (NM_182692) Human Over-expression Lysate |
|||
| E45H15955-2 | EnoGene | each | 395 EUR |
SRPK2 (NM_182691) Human Over-expression Lysate |
|||
| E45H16973-2 | EnoGene | 20 ug | 395 EUR |
SRPK1 (NM_003137) Human Over-expression Lysate |
|||
| LS006732 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of SFRS protein kinase 1 (SRPK1) |
|||
SRPK2 (NM_182692) Human Over-expression Lysate |
|||
| LS006733 | BosterBio | 100ug | 960 EUR |
|
Description: Transient overexpression lysate of SFRS protein kinase 2 (SRPK2), transcript variant 1 |
|||
h FAP Expression Lentivirus |
|||
| LVP1307 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: FAP, containing a RFP-Blasticidin dual selection marker. |
|||
h CD1 Expression Lentivirus |
|||
| LVP1320 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: CD1, containing a RFP-Blasticidin dual selection marker. |
|||
m FAP Expression Lentivirus |
|||
| LVP1326 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for mouse target: FAP, containing a RFP-Blasticidin dual selection marker. |
|||
h VIM Expression Lentivirus |
|||
| LVP1357 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: VIM, containing a RFP-Blasticidin dual selection marker. |
|||
h PXN Expression Lentivirus |
|||
| LVP1358 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: PXN, containing a RFP-Blasticidin dual selection marker. |
|||
m CD8 Expression Lentivirus |
|||
| LVP1363 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for mouse target: CD8, containing a RFP-Blasticidin dual selection marker. |
|||
h TPO Expression Lentivirus |
|||
| LVP1371 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: TPO, containing a RFP-Blasticidin dual selection marker. |
|||
h WAS Expression Lentivirus |
|||
| LVP1429 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: WAS, containing a RFP-Blasticidin dual selection marker. |
|||
m PGR Expression Lentivirus |
|||
| LVP1455 | GenTarget | 1x10^7 IFU/ml x 200ul | 346.5 EUR |
|
Description: Pre-made over-expression lentivirus for mouse target: PGR containing a RFP-Blasticidin dual selection marker. |
|||
h MAG Expression Lentivirus |
|||
| LVP1485 | GenTarget | 1x10^7 IFU/ml x 200ul | 346.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: MAG, containing a RFP-Blasticidin dual selection marker. |
|||
h FST Expression Lentivirus |
|||
| LVP1518 | GenTarget | 1x10^8 IFU/ml x 200ul | 455 EUR |
|
Description: Pre-made lentivirus express human FST gene, containing a RFP-Blasticidin dual selection marker. |
|||
h IL2 Expression Lentivirus |
|||
| LVP293 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Lentivirus express a human IL2 gene with a Blasticidin-RFP fusion marker (Dual selection). |
|||
h ADA Expression Lentivirus |
|||
| LVP923 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: ADA, containing a RFP-Blasticidin dual selection marker. |
|||
h PBK Expression Lentivirus |
|||
| LVP095 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made Lentivirus express human PBK gene, carrying a RFP-Blasticidin fusion marker (Dual selection). |
|||
h IL6 Expression Lentivirus |
|||
| LVP1144 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
|||
h CD4 Expression Lentivirus |
|||
| LVP1152 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: CD4, containing a RFP-Blasticidin dual selection marker. |
|||
h IL4 Expression Lentivirus |
|||
| LVP1161 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: IL4, containing a RFP-Blasticidin dual selection marker. |
|||
h IL7 Expression Lentivirus |
|||
| LVP1162 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: IL7, containing a RFP-Blasticidin dual selection marker. |
|||
pAAV-MCS Expression Vector |
|||
| MBS169528-001mg | MyBiosource | 0.01mg | 695 EUR |
pAAV-MCS Expression Vector |
|||
| MBS169528-5x001mg | MyBiosource | 5x0.01mg | 2955 EUR |
pAAV-MCS Expression Vector |
|||
| VPK-410 | Cell Biolabs | 10 µg | 444 EUR |
ExoPure? Reagent (Overall Exosome Isolation, urine) |
|||
| M1003-25 | Biovision | each | 992.4 EUR |
ExoPure? Reagent (Overall Exosome Isolation, urine) |
|||
| M1003-50 | Biovision | each | 1083.6 EUR |
FlashBAC - Baculovirus Expression System (96 reactions) |
|||
| GWB-6C34E3 | GenWay Biotech | Kit | Ask for price |
FlashBAC - Baculovirus Expression System (5 reactions) |
|||
| GWB-7676BB | GenWay Biotech | Kit | Ask for price |
FlashBAC - Baculovirus Expression System(24 reactions) |
|||
| GWB-EB1FF8 | GenWay Biotech | Kit | Ask for price |
h OCT4 expression Adenovirus |
|||
| AVP013 | GenTarget | 1x109 IFU/ml x 200ul | 206.5 EUR |
|
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in DMEM medium. |
|||
h SOX2 expression Adenovirus |
|||
| AVP014 | GenTarget | 1x109 IFU/ml x 50ul | 206.5 EUR |
|
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in DMEM medium. |
|||
h CBX7 Expression Lentivirus |
|||
| LVP1308 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: CBX7, containing a RFP-Blasticidin dual selection marker. |
|||
h ACE2 Expression Lentivirus |
|||
| LVP1310 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: ACE2, containing a RFP-Blasticidin dual selection marker. |
|||
h Rab7 Expression Lentivirus |
|||
| LVP1315 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: Rab7, containing a RFP-Blasticidin dual selection marker. |
|||
h Rab5 Expression Lentivirus |
|||
| LVP1316 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: Rab5, containing a RFP-Blasticidin dual selection marker. |
|||
m ASPA Expression Lentivirus |
|||
| LVP1317 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for mouse target: ASPA, containing a RFP-Blasticidin dual selection marker. |
|||
h CD44 Expression Lentivirus |
|||
| LVP1318 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: CD44, containing a RFP-Blasticidin dual selection marker. |
|||
h MFN2 Expression Lentivirus |
|||
| LVP1327 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: MFN2, containing a RFP-Blasticidin dual selection marker. |
|||
h ANO1 Expression Lentivirus |
|||
| LVP1344 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: ANO1 containing a RFP-Blasticidin dual selection marker. |
|||
h FGL2 Expression Lentivirus |
|||
| LVP1346 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: FGL2, containing a RFP-Blasticidin dual selection marker. |
|||
h CCR2 Expression Lentivirus |
|||
| LVP1354 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: CCR2, containing a RFP-Blasticidin dual selection marker. |
|||
h NEFL Expression Lentivirus |
|||
| LVP1360 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: NEFL, containing a RFP-Blasticidin dual selection marker. |
|||
h NOS2 Expression Lentivirus |
|||
| LVP1367 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: NOS2, containing a RFP-Blasticidin dual selection marker. |
|||
h BMI1 Expression Lentivirus |
|||
| LVP1372 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: BMI1, containing a RFP-Blasticidin dual selection marker. |
|||
h PSCA Expression Lentivirus |
|||
| LVP1374 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: PSCA, containing a RFP-Blasticidin dual selection marker. |
|||
h POLQ Expression Lentivirus |
|||
| LVP1421 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: POLQ containing a RFP-Blasticidin dual selection marker. |
|||
h ARSA Expression Lentivirus |
|||
| LVP1425 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: ARSA, containing a RFP-Blasticidin dual selection marker. |
|||
h IDUA Expression Lentivirus |
|||
| LVP1426 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: IDUA, containing a RFP-Blasticidin dual selection marker. |
|||
h SGSH Expression Lentivirus |
|||
| LVP1427 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: SGSH, containing a RFP-Blasticidin dual selection marker. |
|||
h CYBB Expression Lentivirus |
|||
| LVP1430 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: CYBB, containing a RFP-Blasticidin dual selection marker. |
|||
h CAV1 Expression Lentivirus |
|||
| LVP1431 | GenTarget | 1x10^7 IFU/ml x 200ul | 276.5 EUR |
|
Description: Over-expression lentivirus for human target: CAV1, containing a RFP-Blasticidin dual selection marker. |
|||
m INS2 Expression Lentivirus |
|||
| LVP1456 | GenTarget | 1x10^7 IFU/ml x 200ul | 346.5 EUR |
|
Description: Pre-made over-expression lentivirus for mouse target: INS2 containing a RFP-Blasticidin dual selection marker. |
|||
h ROR1 Expression Lentivirus |
|||
| LVP1458 | GenTarget | 1x10^7 IFU/ml x 200ul | 346.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: ROR1, containing a RFP-Blasticidin dual selection marker. |
|||
h DGKA Expression Lentivirus |
|||
| LVP1468 | GenTarget | 1x10^7 IFU/ml x 200ul | 346.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: DGKA, containing a RFP-Blasticidin dual selection marker. |
|||
h REST_HA Expression Lentivirus |
|||
| LVP1475 | GenTarget | 1x10^7 IFU/ml x 200ul | 346.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: REST, containing a RFP-Blasticidin dual selection marker. |
|||
h UBR7 Expression Lentivirus |
|||
| LVP1483 | GenTarget | 1x10^7 IFU/ml x 200ul | 346.5 EUR |
|
Description: Pre-made over-expression lentivirus for human target: UBR7, containing a RFP-Blasticidin dual selection marker. |
|||
h MMP1 Expression Lentivirus |
|||
| LVP1516 | GenTarget | 1x10^8 IFU/ml x 200ul | 455 EUR |
|
Description: Pre-made lentivirus express human MMP1 gene, containing a RFP-Blasticidin dual selection marker. |
|||
h BDNF Expression Lentivirus |
|||
| LVP1520 | GenTarget | 1x10^8 IFU/ml x 200ul | 455 EUR |
|
Description: Pre-made lentivirus express human BDNF gene, containing a RFP-Blasticidin dual selection marker. |
|||
m CCL5 Expression Lentivirus |
|||
| LVP1619 | GenTarget | 1x10^8 IFU/ml x 200ul | 455 EUR |
|
Description: Pre-made lentivirus express mouse CCL5 gene, containing a RFP-Blasticidin dual selection marker. |
|||
h TET2 Expression Lentivirus |
|||
| LVP875 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made lentivirus express human target: TET2 (tet methylcytosine dioxygenase 2). It contains a RFP-Blasticidin dual selection marker. |
|||
h TET3 Expression Lentivirus |
|||
| LVP876 | GenTarget | 1x107 IFU/ml x 200ul | 276.5 EUR |
|
Description: Pre-made over-expression lentivirus for expressing human target: TET3 (tet methylcytosine dioxygenase 3), [alternative names: hCG_40738]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_001287491.1 . It also contains a RFP-Blasticidin dual selection marker. |
|||
By stopping peptide manufacturing from cell proteins, these inhibitors block the meeting of class I molecules. Therefore, the proteasome catalyzes the degradation of the overwhelming majority of cell proteins and generates most peptides offered on MHC class I molecules.